Skip to main content

Table 3 RA patients association between neuromuscular outcomes and clinical characteristics controlled by physical activity level

From: Quadriceps muscle properties in rheumatoid arthritis: insights about muscle morphology, activation and functional capacity

 TUGTorqueVL RMSMuscle thicknessPennation AngleFascicle Length
Disease durationr = −0.030r = 0.180r = 0.224r = −0.003r = −0.310r = 0.318
p = 0.879p = 0.328p = 0.244p = 0.988p = 0.102p = 0.093
DAS28-ESRr = −0.248r = 0.161r = −0.202r = 0.036r = −0.126r = 0.161
p = 0.194p = 0.404p = 0.294p = 0.851p = 0.515p = 0.404
HAQr = −0.119r = − 0.017r = − 0.161r = − 0.013r = − 0.081r = − 0.057
p = 0.539p = 0.929p = 0.403p = 0.948p = 0.676p = 0.770
Current dose of GCr = −0.201r = 0.069r = −0.104r = 0.131r = 0.092r = 0.018
p = 0.296p = 0.721p = 0.592p = 0.498p = 0.634p = 0.927
Accumulated dose of GCr = −0.172r = 0.125r = −0.030r = 0.084r = −0.121r = 0.164
p = 0.373p = 0.518p = 0.877p = 0.663p = 0.531p = 0.395
Painr = −0.088r = 0.076r = −0.002r = 0.232r = 0.128r = 0.111
p = 0.649p = 0.697p = 0.993p = 0.225p = 0.509p = 0.566
  1. DAS28-ESR Disease Activity Score-28 with Erythrocyte Sedimentation Rate, HAQ Health Assessment Questionnaire, GC Glucocorticoids